Press "Enter" to skip to content

Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on latest steps to strengthen FDA’s 510(k) program for premarket review of medical devices

FDA takes more steps toward strengthening 510(k) program for premarket review of medical devices

Also Read:   FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicines